1. Aksu, O., Mackler, B., Shepard, T. H., and Lemire, R. J. 1968. Studies of the development of congenital anomalies in embryos of riboflavin-deficient, galactoflavin fed rats. II. Role of the terminal electron transport systems, Teratology 1:93–102.
2. Bertrand, M., Florio, R., Magat, A., and Delatour, P. 1964. Sur la potentialisations des effets embryotoxiques du thalidomide chez la ratte, C. R. Soc. Biol. (Paris) 158:737.
3. Braun, K., Bromberg, Y. M., and Brzezinski, A. 1945. Riboflavin deficiency in pregnancy, J. Obstet. Gynaecol. Brit. Commonw. 52:43.
4. Brent, R. L., and Jensh, R. P. 1967. Intra-uterine growth retardation, Adv. Teratol. 2:139–227.
5. Brzezinski, A., Bromberg, Y. M., and Braun, K. 1947. Riboflavin deficiency in pregnancy. Its relationship to the course of pregnancy and to the condition of the foetus, J. Obstet. Gynaecol. Brit. Commonw. 54:182–186.